Call Us08045479576
Glibenclamide .

Glibenclamide .

25.00 - 50.00 INR

Product Details:

  • Molecular Weight 516 g/mol Grams (g)
  • Storage Room Temperature
  • Molecular Formula C23H27ClN3NaO5S
  • Medicine Name Glibenclamide
  • Type Pharmaceutical Intermediates
  • Grade Medicine Grade
  • Physical Form Powder
  • Click to View more
X

Glibenclamide . Price And Quantity

  • 25 Kilograms
  • 25.00 - 50.00 INR

Glibenclamide . Product Specifications

  • Medicine Grade
  • Room Temperature
  • 516 g/mol Grams (g)
  • Glibenclamide
  • Powder
  • Pharmaceutical Intermediates
  • C23H27ClN3NaO5S

Glibenclamide . Trade Information

  • Cash in Advance (CID) Cash Advance (CA)
  • 1000 Kilograms Per Day
  • 7 Days
  • Western Europe Australia North America Eastern Europe Middle East Central America South America Asia Africa

Product Description

Glibenclamide in the offering is of high quality and highly demanded for its purity and effectiveness. It is safely packaged and supplied within India as well as outside India. Diabetes mellitus type two is treated with Glibenclamide, also called glyburide. Diet and exercise are recommended in conjunction with this supplement. It may be combined with other antidiabetic medications. It should not be used by itself for diabetes mellitus type 1. Your pancreas produces more insulin when you take glibenclamide. Sugar levels in your blood are reduced by this.

Technical Specifications:

  • CAS ID: 10238-21-8
  • Formula: C23H28ClN3O5S
  • Molar mass: 494.004 g/mol
  • Synonyms: Glyburide
  • melting point: 169 C
  • Boiling point : 705.770.0 C at 760 mmHg
  • Purity: 99.0%
How does it work:
  • Glibenclamide increases insulin production in the pancreas. Your blood sugar is reduced as a result.
  • The drug acts by inhibiting the ATP-sensitive K+ channels, which results in insulin secretion and depolarization of cells. Additionally, the drug can have extrapancreatic effects on the liver, heart muscles, skeletal muscles, and smooth muscles.

Applications Or where it is used:

Type 2 diabetes mellitus is treated with glibenclamide. When combined with nutrition and exercise, this antidiabetic medication controls blood sugar levels in adults with type 2 diabetes. The pancreas releases more insulin to lower blood glucose levels.

How to use:

Your doctor usually recommends that you take this medication once a day with breakfast or with the first meal you eat that day. The patient may be advised to take this drug twice a day, especially those taking higher doses. Dosages are determined by your health conditions and treatment response. If you already take another diabetes medication, your doctor will tell you how to stop it and begin glyburide. Take glyburide four hours before colesevelam if you are also taking it.

Dosage of usage:
  • Type 2 Diabetes Mellitus
  • Regular tablets:
  • Initial: 2.5-5 mg PO qDay
  • Maintenance: 1.25-20 mg PO qDay or q12hr
  • Do not exceed 20 mg/day
  • Administer q12hr for doses >10 mg/day
  • Transferring from insulin therapy to glyburide
  • -Current insulin dose <20 units: Stop taking insulin and start glyburide dose at 2.5-5 mg/day (regular) or 1.5-3 mg/day (micronized)
  • -Current insulin dose 20-40 units: Stop taking insulin and start glyburide dose at 5 mg/day (regular) or 3 mg/day (micronized)
Side effects:

Weight gain, nausea, heartburn, and stomach fullness are possible side effects. Tell your doctor or pharmacist if you experience any of these effects. Consult a doctor immediately if anyone experiences any serious side effects, such as easy bleeding/bruising, dark urine, stomach pain, yellowing eyes/skin, unusual tiredness, unusual weight gain, mood swings, seizures, etc. 

Warnings and precautions while using this product:

Glyburide must not be taken by anyone who is allergic to it or has any other allergies. There may be inactive ingredients in this product that may cause allergic reactions. More information can be obtained from your pharmacist. Due to lower or higher blood sugar levels, you may experience blurred vision, dizziness, or drowsiness. It is not safe to drive, operate machinery, or perform any other activity that requires alertness or vision clarity until you are sure you can perform such activities safely. Drinking alcohol can increase your risk of low blood sugar when taking this medication. Sometimes alcohol interacts with glyburide and causes a serious reaction, which can cause symptoms like nausea, dizziness, or vomiting. 

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category